NO310109B1 - Naftalenderivater og mellomprodukter ved deres fremstilling - Google Patents

Naftalenderivater og mellomprodukter ved deres fremstilling Download PDF

Info

Publication number
NO310109B1
NO310109B1 NO962527A NO962527A NO310109B1 NO 310109 B1 NO310109 B1 NO 310109B1 NO 962527 A NO962527 A NO 962527A NO 962527 A NO962527 A NO 962527A NO 310109 B1 NO310109 B1 NO 310109B1
Authority
NO
Norway
Prior art keywords
pyridyl
group
bis
hydroxymethyl
dimethoxynaphthalene
Prior art date
Application number
NO962527A
Other languages
English (en)
Norwegian (no)
Other versions
NO962527L (no
NO962527D0 (no
Inventor
Tatsuzo Ukita
Katsuo Ikezawa
Shinsuke Yamagata
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of NO962527D0 publication Critical patent/NO962527D0/no
Publication of NO962527L publication Critical patent/NO962527L/no
Publication of NO310109B1 publication Critical patent/NO310109B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO962527A 1995-06-15 1996-06-14 Naftalenderivater og mellomprodukter ved deres fremstilling NO310109B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14928895 1995-06-15

Publications (3)

Publication Number Publication Date
NO962527D0 NO962527D0 (no) 1996-06-14
NO962527L NO962527L (no) 1996-12-16
NO310109B1 true NO310109B1 (no) 2001-05-21

Family

ID=15471914

Family Applications (1)

Application Number Title Priority Date Filing Date
NO962527A NO310109B1 (no) 1995-06-15 1996-06-14 Naftalenderivater og mellomprodukter ved deres fremstilling

Country Status (21)

Country Link
US (3) US6005106A (fr)
EP (1) EP0748805B1 (fr)
KR (1) KR100435247B1 (fr)
CN (1) CN1063748C (fr)
AR (1) AR002483A1 (fr)
AT (1) ATE164843T1 (fr)
AU (1) AU706156B2 (fr)
BG (1) BG62521B1 (fr)
BR (1) BR9602802A (fr)
CA (1) CA2178974C (fr)
DE (1) DE69600221T2 (fr)
ES (1) ES2116131T3 (fr)
HK (1) HK1010116A1 (fr)
HU (1) HU222340B1 (fr)
IL (1) IL118469A (fr)
MY (1) MY121606A (fr)
NO (1) NO310109B1 (fr)
RU (1) RU2129120C1 (fr)
SG (1) SG47152A1 (fr)
TW (1) TW349098B (fr)
ZA (1) ZA964652B (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID19155A (id) * 1996-12-13 1998-06-18 Tanabe Seiyaku Co Turunan-turunan piridin, pembuatannya dan intermediet untuk pembuatannya
JPH1171351A (ja) * 1997-08-29 1999-03-16 Ss Pharmaceut Co Ltd 置換キノロン誘導体及びこれを含有する医薬
EP1080162B1 (fr) 1998-05-05 2004-03-10 Massachusetts Institute Of Technology Polymeres emissifs et dispositifs renfermant ces polymeres
US20050147534A1 (en) 1998-05-05 2005-07-07 Massachusetts Institute Of Technology Emissive sensors and devices incorporating these sensors
TR200201317T2 (tr) 1999-08-21 2002-11-21 Byk Gulden Lomberg Chemische Fabrik Gmbh Sinerjistik kombinasyon.
WO2002094321A1 (fr) * 2001-05-23 2002-11-28 Tanabe Seiyaku Co., Ltd. Compositions favorisant la guérison d'une fracture osseuse
CN1537018A (zh) * 2001-05-23 2004-10-13 田边制药株式会社 一种用于软骨疾病再生治疗的组合物
TWI221838B (en) 2001-08-09 2004-10-11 Tanabe Seiyaku Co Pyrazinoisoquinoline compound or naphthalene compound
WO2003049702A2 (fr) * 2001-12-10 2003-06-19 Amgen Inc. Ligands de recepteur vanilloide et utilisation de ceux-ci dans des traitements
US20050043315A1 (en) * 2002-01-02 2005-02-24 Hideo Tsutsumi Aminopyrimidine compounds, processes for their preparation and pharmaceutical compositions containing them
DE60335635D1 (de) * 2002-05-22 2011-02-17 Amgen Inc Aminopyrimidin-derivate zur verwendung als vanilloid-rezeptor-liganden zur behandlung von schmerzen
EP1717220A3 (fr) * 2002-08-08 2007-08-22 Amgen, Inc Ligands du récepteur vanilloide et leur utilisation dans des traitements
NZ542304A (en) 2003-03-14 2009-07-31 Ono Pharmaceutical Co Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
MXPA05010373A (es) 2003-04-01 2005-12-05 Applied Research Systems Inhibidores de fosfodiesterasas en infertilidad.
AU2004241455A1 (en) * 2003-05-16 2004-12-02 University Of Chicago Optical fractionation methods and apparatus
WO2005033105A2 (fr) * 2003-09-30 2005-04-14 Amgen Inc. Ligands de recepteur vanilloide et leur utilisation dans certains traitements
MY139645A (en) * 2004-02-11 2009-10-30 Amgen Inc Vanilloid receptor ligands and their use in treatments
JP2007522233A (ja) * 2004-02-11 2007-08-09 アムジエン・インコーポレーテツド バニロイド受容体リガンド及び治療におけるそれらの使用
US8143404B2 (en) 2004-09-13 2012-03-27 Ono Pharmaceutical Co., Ltd Nitrogenous heterocylic derivative and medicine containing the same as an active ingredient
WO2006034081A2 (fr) 2004-09-17 2006-03-30 Massachusetts Institute Of Technology Polymeres destines a la detection d'analytes
TWI339578B (en) 2004-10-29 2011-04-01 Mitsubishi Tanabe Pharma Corp Use of a pyridine compound for the preparation of a medicament for the treatment of skin lesions
US7301022B2 (en) * 2005-02-15 2007-11-27 Amgen Inc. Vanilloid receptor ligands and their use in treatments
WO2006113769A1 (fr) * 2005-04-15 2006-10-26 Amgen Inc. Ligands recepteurs de vanilloide et leur utilisation dans les traitements
PL2371820T3 (pl) 2005-10-04 2014-01-31 Mitsubishi Tanabe Pharma Corp Optycznie aktywny cykliczny alkohol i sposób jego wytwarzania
JP4658134B2 (ja) 2005-10-04 2011-03-23 田辺三菱製薬株式会社 光学活性４−ヒドロキシ−１，２，３，４−テトラヒドロキノリン化合物の製法
AU2006300478B2 (en) * 2005-10-05 2010-06-17 Mitsubishi Tanabe Pharma Corporation Dermatitis treating agent
JPWO2007105637A1 (ja) 2006-03-10 2009-07-30 小野薬品工業株式会社 含窒素複素環誘導体およびそれらを有効成分とする薬剤
WO2007112347A1 (fr) 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Inhibiteurs de la dipeptidyl peptidase
WO2008042289A2 (fr) 2006-09-29 2008-04-10 Massachusetts Institute Of Technology Technique synthétique polymérique
US8802447B2 (en) 2006-10-05 2014-08-12 Massachusetts Institute Of Technology Emissive compositions with internal standard and related techniques
US20090215189A1 (en) 2006-10-27 2009-08-27 Massachusetts Institute Of Technology Sensor of species including toxins and chemical warfare agents
US20080207659A1 (en) * 2007-02-15 2008-08-28 Asit Kumar Chakraborti Inhibitors of phosphodiesterase type 4
JP2010524857A (ja) * 2007-04-10 2010-07-22 ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア フェン−ナフタレン及びフェン−キノリン誘導体、及びアミロイドプラークに結合させ、そして造影するための使用
US9125807B2 (en) 2007-07-09 2015-09-08 Incept Llc Adhesive hydrogels for ophthalmic drug delivery
US20140121240A1 (en) * 2011-06-28 2014-05-01 Maruho Co., Ltd. Novel pharmaceutical composition
EP2749558A4 (fr) 2011-08-25 2014-11-19 Mitsubishi Tanabe Pharma Corp Procédé de production d'un composé de naphtalène optiquement actif
US11970440B1 (en) 2023-10-30 2024-04-30 King Faisal University 8-(3-chlorobenzylideneamino)naphthalene-1,3-disulfonic acid as an antioxidant compound
US11987543B1 (en) 2023-10-31 2024-05-21 King Faisal University 8-(4-bromobenzylideneamino)naphthalene-1,3-disulfonic acid as an antioxidant compound
US11932593B1 (en) 2023-10-31 2024-03-19 King Faisal University 8-(3-bromobenzylideneamino)naphthalene-1,3-disulfonic acid as an antioxidant compound

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3042156B2 (ja) * 1992-02-20 2000-05-15 田辺製薬株式会社 ナフタレン誘導体、その製法及びその合成中間体
US5342841A (en) * 1992-03-12 1994-08-30 Kyowa Hakko Kogyo Co., Ltd. Xanthine derivatives
EP0731084B1 (fr) * 1995-03-03 2002-09-25 Rolic AG Dérivés naphtyl photoréticulables

Also Published As

Publication number Publication date
KR100435247B1 (ko) 2004-09-10
DE69600221T2 (de) 1998-08-06
EP0748805B1 (fr) 1998-04-08
AU706156B2 (en) 1999-06-10
IL118469A0 (en) 1996-09-12
DE69600221D1 (de) 1998-05-14
ATE164843T1 (de) 1998-04-15
CA2178974C (fr) 2006-06-06
CN1142497A (zh) 1997-02-12
IL118469A (en) 2000-08-13
KR970001343A (ko) 1997-01-24
NO962527L (no) 1996-12-16
US6005106A (en) 1999-12-21
EP0748805A1 (fr) 1996-12-18
SG47152A1 (en) 1998-03-20
ZA964652B (en) 1996-12-12
HUP9601652A1 (en) 1997-09-29
ES2116131T3 (es) 1998-07-01
US5969140A (en) 1999-10-19
BR9602802A (pt) 1998-10-06
CA2178974A1 (fr) 1996-12-16
CN1063748C (zh) 2001-03-28
BG100656A (en) 1997-09-30
TW349098B (en) 1999-01-01
MY121606A (en) 2006-02-28
AR002483A1 (es) 1998-03-25
BG62521B1 (bg) 2000-01-31
RU2129120C1 (ru) 1999-04-20
NO962527D0 (no) 1996-06-14
HK1010116A1 (en) 1999-06-11
US6214996B1 (en) 2001-04-10
HU222340B1 (hu) 2003-06-28
HU9601652D0 (en) 1996-08-28
AU5469396A (en) 1997-01-02

Similar Documents

Publication Publication Date Title
NO310109B1 (no) Naftalenderivater og mellomprodukter ved deres fremstilling
US5118689A (en) Piperidine derivative and pharmaceutical composition containing the same
EP0178035B1 (fr) 1,N-Diarylpyrazol-3-amines anti-inflammatoires, compositions les contenant et leur préparation
US6303600B1 (en) Substituted azabicyclic compounds
AU695817B2 (en) Thiazole derivative as protein kinase C inhibitors
US20030212276A1 (en) Process for the preparation of 7-substituted-3 quinolinecarbonitriles
JPH11514361A (ja) Ｈ＋−ＡＴＰａｓｅとしての複素環式化合物
US4992433A (en) Novel pyridazinamine derivatives
KR100416833B1 (ko) 피리딘유도체,피리딘유도체의제조방법및그를위한중간체
US4738970A (en) Benzimidazolyl-thio-tetrahydroquinolines and anti-peptic ulcer compositions containing the same
US5231184A (en) Pridazinamine derivatives
NO318988B1 (no) Ftalazinderivater som fosfodiesterase 4-inhibitorer
DK168291B1 (da) N-substituerede diphenylpiperidiner, fremgangsmåde til fremstilling deraf, lægemiddel indeholdende forbindelserne samt anvendelse af forbindelserne samt anvendelse af forbindelserne til fremstilling af et lægemiddel til anvendelse til forebyggelse eller behandling af fedme
JP3033090B2 (ja) ナフタレン誘導体、その製法及びその合成中間体
CA2060945A1 (fr) Composes pyridine
JPH10502660A (ja) ヘリコバクター細菌に対抗するためのピリジルチオ化合物
JP3237109B2 (ja) 医薬組成物
US5849765A (en) Tetrahydropyridine derivatives as dopamine receptor subtype ligands
JPH10291988A (ja) 複素環式化合物
JPH10226685A (ja) ピリジン誘導体、その製法及びその合成中間体
US4963566A (en) Benzimidazolyl-sulfinyl-tetrahydroquinolines
US5106973A (en) Pyridzainamine derivatives
JP2000063275A (ja) 医薬組成物
AU4145299A (en) Quinoline-aminomethyl-pyridyl derivatives with anti-helicobacter activity
JPS6320433B2 (fr)

Legal Events

Date Code Title Description
MK1K Patent expired